# Phibro Animal Health Corporation > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Phibro Animal Health Corporation). ## Overview Phibro Animal Health Corp. develops, manufactures, and markets animal health and mineral nutrition products for food-producing animals and companion animals. It also sells selected performance products used in personal care, industrial chemicals, and chemical catalysts, with operations and distribution spanning the United States and many international markets. ## Products & services • Animal health products: antibacterials, anticoccidials, vaccines • Nutritional specialty products for livestock and companion animals • Mineral nutrition products, including zinc and trace minerals • Performance products for personal care and industrial uses • Processing aids used in ethanol fermentation - **Animal Health** (74%) — Medicines, vaccines, adjuvants, and related products for livestock and companion animals. - **Mineral Nutrition** (20%) — Mineral-based feed additives that support animal health and diet fortification. - **Performance Products** (6%) — Ingredients sold to personal care, industrial chemical, and catalyst customers. - Animal health products: antibacterials, anticoccidials, vaccines - Nutritional specialty products for livestock and companion animals - Mineral nutrition products, including zinc and trace minerals - Performance products for personal care and industrial uses - Processing aids used in ethanol fermentation ## Customers Phibro sells primarily to livestock producers, integrated poultry, swine, beef and dairy operations, animal feed manufacturers, veterinarians, nutritionists, wholesalers, and distributors. It also serves a smaller set of industrial customers that buy performance ingredients for personal care and chemical applications. The business is built around recurring demand from animal production cycles and technical support relationships with farm operators and veterinary channels. - **Integrated livestock producers** (primary) — Large poultry, swine, beef, and dairy operators buy health and nutrition products to manage herd and flock performance. - **Animal feed manufacturers** (primary) — Feed companies buy mineral nutrition and specialty additives to fortify rations and improve animal outcomes. - **Veterinarians and technical advisors** (secondary) — They influence product selection and use animal health products in disease prevention and treatment programs. - **Distributors and wholesalers** (secondary) — They purchase and resell products in markets where Phibro lacks direct commercial presence. - **Industrial ingredient customers** (emerging) — Personal care, industrial chemical, and catalyst customers buy performance ingredients for formulation and processing. - Integrated poultry, swine, beef, and dairy producers - Animal feed manufacturers buying mineral nutrition and additives - Veterinarians and nutritionists specifying treatment and feed programs - Wholesalers and distributors extending market reach in local markets - Personal care and industrial chemical customers for performance products ## Geography Phibro markets products in approximately 90 countries across North America, Latin America, Asia Pacific, Europe, Africa, and the Middle East. The company has a direct commercial presence in some markets and uses distributors in others, which broadens reach but also creates exposure to local regulation, import rules, and livestock-cycle differences. Its business is especially tied to regions with concentrated commercial livestock production. - Sales span approximately 90 countries across six major regions - North America is important for livestock and performance products - Latin America is a key market for poultry and vaccine demand - Asia Pacific and Europe are important for direct and distributor sales - Africa and the Middle East add geographic diversification ## Strategy Phibro’s strategy centers on serving large commercial livestock producers with a broad portfolio that combines animal health and mineral nutrition. The company also uses technical support, distribution relationships, and cross-selling between product lines to deepen customer relationships and expand access to new accounts. A longer-term priority is building its companion animal presence while maintaining its core livestock franchise. - **Deepen livestock franchise** (medium-term) — The core business is concentrated in poultry, swine, beef, and dairy, where scale and technical support matter. - **Cross-sell animal health and mineral nutrition** (short-term) — Complementary products can increase wallet share and reduce customer concentration risk. - **Expand companion animal exposure** (long-term) — Companion animal products can diversify the portfolio beyond livestock cycles. - Focus on large commercial livestock farms and integrated producers - Use cross-selling between animal health and mineral nutrition - Leverage technical support to strengthen customer relationships - Expand companion animal offerings over time - Maintain broad geographic reach through direct and distributor channels ## Risks Phibro is exposed to livestock disease outbreaks, shifts in protein demand, and regulatory constraints that can affect product usage and farm economics. Its global footprint also creates exposure to import restrictions, sanctions, foreign exchange, cybersecurity, and integration or execution risk around acquisitions and new product lines. - **Animal disease outbreaks** [high] — Disease events can change treatment patterns, herd sizes, and customer purchasing behavior. - **Demand swings in animal protein** [high] — Lower protein consumption can lead producers to reduce herd or flock sizes and cut product usage. - **Regulatory and import restrictions** [medium] — Animal health products are subject to local approvals, import rules, and extra-label use limits. - **Cybersecurity and IT disruption** [medium] — Operational systems support manufacturing, sales, and technical services, so breaches can disrupt business. - **Foreign exchange and geopolitical exposure** [medium] — International sales and intercompany activity create currency and sanctions-related volatility. - Animal disease outbreaks can reduce demand for health products - Protein demand swings can change herd and flock sizes - Import rules and regulations can delay or limit sales in some markets - Cybersecurity or system failures could disrupt operations - Acquisitions and new products add execution and integration risk ## Accounting Investors should watch acquisition accounting, intangible asset valuation, and restructuring or integration charges because these can materially affect reported earnings. The business also has meaningful foreign currency effects from international operations, and seasonality can arise from livestock cycles, customer purchasing timing, and regulatory delays. - **Goodwill and intangible asset impairment** — Write-downs could materially affect earnings and equity. - **Acquisition-related accounting** — Affects amortization, purchase accounting, and non-GAAP adjustments. - **Foreign currency translation and transaction gains/losses** — Can create volatility in reported operating results. - **Seasonality and customer purchasing timing** — Makes quarter-to-quarter comparisons less linear. - Acquisition accounting affects goodwill and intangible assets - Impairment testing matters for developed technology and customer relationships - Foreign currency gains and losses can move reported results - Seasonality and purchase timing affect quarterly comparability - Non-GAAP adjustments may exclude acquisition and restructuring items --- *Last updated: 2026-04-29T04:46:03.175044+00:00*